- US12570751utility2026Binding Agents Binding to PD-L1 and CD137 and Use Thereof0 cites
- US12460198utility2025Method for Reducing Immunogenicity of RNA0 cites
- US12433911utility2025Preparation and Storage of Liposomal RNA Formulations Suitable for Therapy0 cites
- US12410258utility2025Antibodies Capable of Binding to OX40, Variants Thereof and Uses Thereof0 cites
- US12398214utility2025Binding Agents Binding to Epcam and CD1370 cites
- US12385049utility2025Modification of RNA, Producing an Increased Transcript Stability and Translation Efficiency0 cites
- US12378531utility2025Use of RNA for Reprogramming Somatic Cells0 cites
- US12361554utility2025Systems and Methods for Segmentation and Measurement of a Skin Abnormality0 cites
- US12346849utility2025System for Supporting Teamwork by Means of Augmented Reality0 cites
- US12338448utility2025Trans-replicating RNA0 cites
- US12305210utility2025In Vitro Transcription Technologies0 cites
- US12270813utility2025Methods for Predicting the Usefulness of Disease Specific Amino Acid Modifications for Immunotherapy0 cites
- US12263215utility2025Cytotoxic Immunostimulating Particles and Uses Thereof0 cites
- US12220484utility2025Stable Formulations of Lipids and Liposomes0 cites
- US12208136utility2025Coronavirus Vaccine0 cites
- US12186387utility2025Coronavirus Vaccine0 cites
- US12153041utility2024Methods for Predicting the Usefulness of Proteins or Protein Fragments for Immunotherapy0 cites
- US12133899utility2024Coronavirus Vaccine0 cites
- US12077596utility2024Multispecific Antibodies Against CD40 and CD1370 cites
- US12059498utility2024Preparation and Storage of Liposomal RNA Formulations Suitable for Therapy0 cites
Page 1 of 2Next →